Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG)

Gynecol Oncol. 1990 Jun;37(3):359-62. doi: 10.1016/0090-8258(90)90367-t.
No abstract available

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Carcinoma, Squamous Cell / drug therapy*
  • Female
  • Hematologic Diseases / chemically induced
  • Humans
  • Lomustine / administration & dosage
  • Lung Diseases / chemically induced
  • Methotrexate / administration & dosage
  • Middle Aged
  • Vulvar Neoplasms / drug therapy*

Substances

  • Bleomycin
  • Lomustine
  • Methotrexate